For the first time in more than a decade, the Infectious Diseases Society of America updated its guidelines for complicated ...

The FDA has issued a complete response letter to Replimune indicating it is unable to approve the biologics license ...

A functional precision medicine platform intends to streamline cancer treatment by matching patients against a battery of FDA ...

CMS issued the 2026 Medicare Physician Fee Schedule, or PFS, proposed rule on July 14.It includes a 0.75% increase to the ...

Baseline BMI may play a significant role in improving exercise capacity, body weight and BP among patients with HF with ...

Danegaptide, a potential oral therapy for nonproliferative diabetic retinopathy, is advancing to a phase 2 trial after ...

In 2008, the U.S. House of Representatives designated July as Bebe Moore Campbell National Minority Mental Health Awareness ...

Let’s talk about sex.An online survey of more than 1,700 breast cancer survivors showed that most respondents experienced ...

The FDA granted an orphan drug designation to novel hedgehog pathway inhibitor taladegib, also known as ENV-101, for treating ...

An oral neutrophil modulator appeared safe and demonstrated signals of efficacy in patients with moderate to severe ...

Members of an FDA expert panel discussed the risks and benefits of selective serotonin reuptake inhibitors, or SSRIs, for ...

The FDA appointed George F. Tidmarsh, MD, PhD, the director of the Center for Drug Evaluation and Research, the agency ...